Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2008-10-06
2010-12-07
Kemmerer, Elizabeth C (Department: 1646)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S002600
Reexamination Certificate
active
07846901
ABSTRACT:
Disclosed herein are a composition for prevention or treatment of gastrointestinal damage comprising Substance-P as an active ingredient, a use of Substance-P for the preparation of a medicament for prevention or treatment of gastrointestinal damage, and a method for prevention or treatment of gastrointestinal damage comprising administering a therapeutically effective amount of Substance-P to a mammal.
REFERENCES:
patent: 3608064 (1971-09-01), Lamb
patent: 5594022 (1997-01-01), Horwell et al.
patent: 5981597 (1999-11-01), Wu
patent: 6110939 (2000-08-01), Janssens et al.
patent: 6576638 (2003-06-01), Pompei et al.
patent: 7119071 (2006-10-01), Rameshwar
patent: 7745403 (2010-06-01), Larsen et al.
patent: 2004/0214311 (2004-10-01), Levy
patent: 2006/0127373 (2006-06-01), Son et al.
Son et al. (2006, Mol. Biol. Cell 17 (Suppl.) L57).
K. Bulut, et al.: “Sensory neuropeptides and epithelial cell restitution: the relevance of SP- and CGRP-stimulated mast cells,” Int. J. Colorectal Dis., vol. 23, Feb. 15, 2008, pp. 535-541.
W.P. ter Beek, et al.: “Substance P receptor expression in patients with inflammatory bowel disease Determination by three different techniques, i.e., storage phosphor autoradiography, RT-PCR and immunohistochemistry,” Neuropeptides, vol. 41, Jun. 28, 2007, pp. 301-306.
H. Koon, et al.: “Substance P mediates antiapoptotic responses in human colonocytes by Akt activation,” PNAS, vol. 104, No. 6, Feb. 6, 2007, pp. 2013-2018.
J. Wang, et al.: “Calcitonin Gene-Related Peptide and Substance P Regulate the Intestinal Radiation Response,” Clin Cancer Res, vol. 12(13), Jul. 1, 2006, pp. 4112-4118.
P. Felderbauer, et al.: “Substance P induces intestinal wound healing via fibroblasts—evidence for a TGF-β-dependent effect,” Int. J. Colorectal Dis., vol. 22, May 23, 2007, pp. 1475-1480.
P. Felderbauer et al.: “Substance P induces intestinal wound healing via fibroblasts—evidence for a TGF-β-dependent effect,” Int. J. Colorectal Dis. vol. 22, pp. 1475-1480, 2007.
Hong Hyun Sook
Kim Do Yeon
Son Young Sook
Kemmerer Elizabeth C
Rothwell Figg Ernst & Manbeck P.C.
University-Industry Cooperation Group of Kyunghee University
LandOfFree
Method for inhibiting or treating intestinal damage caused... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for inhibiting or treating intestinal damage caused..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for inhibiting or treating intestinal damage caused... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4222992